Neural Plasticity and Motor Recovery After Upper Extremity Motor Training in People With c-SCI
REPAIR-SCI
Central and Peripheral Neuroplasticity in Cervical Spinal Cord Injury Following Intensive Upper Limb Motor Training
1 other identifier
interventional
44
2 countries
4
Brief Summary
After spinal cord injury (SCI), there is a disruption in neural circuits resulting in paralysis. There is not yet a cure for paralysis. In persons with Cervical SCI (pwC-SCI) recovery of arm-hand function is very important as it has a significant impact on the patients' level of independence and quality of life. Recovery is assumed to involve alterations in both central and peripheral motor systems. Motor training at an intensive dosage potentially provides a powerful stimulus for neurological recovery. This project exploits the peripheral and central neuroplastic effect of an early (\<13 weeks after injury) and intensive (8 weeks of 6 hours in addition to usual care) upper limb motor training program (EIUMT) directed at recovery below the level of the injury in pwC-SCI within an international multi-center randomized controlled trial including 44 pwC-SCI. It has 4 objectives: to investigate 1)central neural plasticity by identifying alterations in cortical neuroplasticity and corticospinal excitability; 2)peripheral neural plasticity by identifying alterations in axonal excitability and number of motor units; 3)behavioral motor recovery of upper limb and 4)relationships between dose dimensions of motor intervention and behavioral and neurophysiological outcome measures after EIUMT. Cutting-edge neurophysiological measures are used to provide insight in the mechanism of neuroplasticity after EIUMT and will be taken before and after EIUMT and at 6 months follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2024
Typical duration for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 14, 2023
CompletedFirst Posted
Study publicly available on registry
October 3, 2023
CompletedStudy Start
First participant enrolled
October 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 28, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 28, 2027
December 12, 2025
December 1, 2025
2.5 years
June 14, 2023
December 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
changes in single pulse TMS: resting motor threshold
to asses changes in cortical reactivity
- before intervention; at 4 weeks (inbetween measure), at 8 weeks (after intervention) and at 6 months follow-up
Changes in Compound Muscle Action Potential (CMAP)
Changes in amplitude of CMAP
- before intervention; at 4 weeks (inbetween measure), at 8 weeks (after intervention) and at 6 months follow-up
changes in GRASSP
Grades redefined assessment of strength sensibility and Prehension
- before intervention; at 8 weeks (after intervention) and at 6 months follow-up
Secondary Outcomes (11)
Single-pulse TMS: Stimulus Response Curve
- before intervention; at 4 weeks (inbetween measure), at 8 weeks (after intervention) and at 6 months follow-up
changes SICI
- before intervention; at 8 weeks (after intervention) and at 6 months follow-up
changes in LICI
- before intervention; at 8 weeks (after intervention) and at 6 months follow-up
changes in MscanFit MUNE
- before intervention; at 4 weeks (inbetween measure), at 8 weeks (after intervention) and at 6 months follow-up
changes in single pulse TMS: mapping
- before intervention; at 8 weeks (after intervention) and at 6 months follow-up
- +6 more secondary outcomes
Other Outcomes (4)
Subjectively perceived session difficulty
measurement of one week during the 2., 5. and 8. week of intervention duration; before and after completion of session
Objective active time
- measurement of one week during the 2., 5. and 8. week of intervention duration
Subjectively perceived session intensity
measurement of one week during the 2., 5. and 8. week of intervention duration; before and after completion of session
- +1 more other outcomes
Study Arms (2)
intensive upper limb training
EXPERIMENTALThe intervention group receives 6 hours of motor training each week upon usual care during 8 weeks. This involves active and targeted motor training of all affected muscles below the injury level in the context of functional activities.
usual care
OTHERThe control group receives only standard rehabilitation and care
Interventions
Intervention group: receive an extra 6 hours of motor training each week (distributed over the week) for 8 weeks. It will involve active and targeted motor training of all affected muscles of the upper limb below the level of the injury within the context of practice of functional activities. Interventions will be goal directed and individualized to the needs of each participant with a focus on training that addresses each person's specific motor problem, promoting motor learning as well as stimulating neural plasticity. All patients will continue to receive usual physiotherapy and usual rehabilitation.
Eligibility Criteria
You may qualify if:
- Traumatic or non-traumatic C-SCI in the preceding 13 weeks; age over 16 years; have an incomplete SCI categorized as AIS C or D or an AIS A SCI with zones of partial motor paralysis (as defined by the International Standards for the Neurological Classification of SCI (ISNCI) and medically stable.
You may not qualify if:
- SCI with ASIA Impairment Scale (AIS) A without zones of partial preservation (decided based on former studies) and expertise of the team; SCI with any significant medical condition that could prevent the person from participating. Patients will be excluded from the measures of central plasticity in the presence of contraindications for TMS application such as epilepsy, metal implants in the brain, defibrillator, pacemaker, and pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Annemie Spoorenlead
- Research Foundation Flanderscollaborator
- University of Aarhuscollaborator
- University of Sydneycollaborator
- University Hospital, Ghentcollaborator
- Universitaire Ziekenhuizen KU Leuvencollaborator
- Adelante, Centre of Expertise in Rehabilitation and Audiologycollaborator
- Rehabilitation Hospital RevArtecollaborator
Study Sites (4)
Revalidatieziekenhuis RevArte
Antwerp, 2650, Belgium
UZGent
Ghent, Belgium
UZLeuven Campus Pellenberg
Leuven, Belgium
Zorggroep Adelante
Hoensbroek, Netherlands
Related Publications (1)
Hrycyk IJ, Bertels N, Tankisi H, Glinsky JV, Oostra K, van Laake-Geelen C, Tedesco Triccas L, Spooren A. Central and peripheral neuroplasticity in cervical spinal cord injury following intensive upper limb motor training: a randomised controlled trial protocol. BMJ Open. 2026 Mar 18;16(3):e107352. doi: 10.1136/bmjopen-2025-107352.
PMID: 41857841DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Annemie Spooren, Prof. Dr.
Hasselt University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Prof. Annemie Spooren
Study Record Dates
First Submitted
June 14, 2023
First Posted
October 3, 2023
Study Start
October 9, 2024
Primary Completion (Estimated)
March 28, 2027
Study Completion (Estimated)
August 28, 2027
Last Updated
December 12, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- during and after data gathering
- Access Criteria
- only for collaborating partners
Pseudomised data will be discussed with Aarhus University because they will assist in data analyses. The protocol will be shared with the partners (Aarhus University, Sydney University, UZ Gent, UZ Leuven, RZ RevArte, and Adelante Zorggroep)